Indications for the use of emergency contraception include sexual assault, unprotected intercourse, condom breakage or slippage, and missed or late doses of hormonal contraceptives, including the oral contraceptive pill, contraceptive patch, contraceptive ring (i.e., improper placement or loss/expulsion), and inject able contraception.Though a battery of contraceptive methods are available and ...

OBJECTIVE This report presents national estimates of sexual activity, contraceptive use, and births among males and females aged 15-19 in the United States in 2006-2010 from the National Survey of Family Growth (NSFG). For selected indicators, data are also presented from the 1988, 1995, and 2002 NSFG, and from the 1988 and 1995 National Survey of Adolescent Males, conducted by the Urban Instit...

OBJECTIVE To estimate 12-month satisfaction and continuation rates of intrauterine device (IUD) and implant users enrolled in the Contraceptive CHOICE Project and compare these measures with women using the oral contraceptive pills (OCPs). METHODS We analyzed 12-month data from the first 5,087 participants enrolled in a prospective cohort study of women in the St. Louis region offered contrac...

BACKGROUND Contraceptive implants, the levonorgestrel-releasing intrauterine system (LNG IUS), and the copperbearing intrauterine device (IUD) are long-acting reversible contraceptives (LARCs) with high contraceptive effectiveness. The cumulative pregnancy rates in the first 3 years of use of LARCs is 0.9 per 100 woman-years. In comparison, the percentages of women experiencing an unintended pr...

Abstract Background Efforts are underway to develop an easy-to-use contraceptive microarray patch (MAP) that could expand the range of self-administrable methods. This paper presents results from a discrete choice experiment (DCE) designed support optimal product design. Methods We conducted DCE survey users and non-users contraception in New Delhi, India (496 women) Ibadan, Nigeria (two versio...

Mesenteric venous thrombosis is a rare cause of abdominal pain, which if left untreated may result in bowel infarction, peritonitis and death. The majority of patients with this illness have a recognizable, predisposing prothrombotic condition. Oral contraceptives have been identified as a predisposing factor for mesenteric venous thrombosis in reproductive-aged women. In the last fifteen years...

BACKGROUND The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects on Mexican population are unknown. The objective of the study was to evaluate if these treatments i...

OBJECTIVE To compare bleeding profiles and satisfaction among women using a norelgestromin/ethinyl estradiol (E2) transdermal contraceptive patch in an extended regimen to those among women using a traditional 28-day patch regimen. METHODS Healthy, regularly menstruating women (N = 239) were randomly assigned (2:1 ratio) to receive the norelgestromin/ethinyl E2 transdermal patch in an extende...